Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Family Medicine | Gynecology | Infections | Internal Medicine | Neurology | Nursing | Pathology | Pediatrics | Pharmacy | Journal

Back to Journal Articles

Flu Shot in Pregnancy Not Tied to Adverse Fetal Outcomes

Last Updated: July 10, 2012.

Exposure to adjuvanted influenza A(H1N1)pdm09 vaccination during pregnancy does not increase the risk of adverse fetal outcomes, and influenza vaccination correlates with a small but significantly increased risk of Guillain-Barré Syndrome, according to two studies published in the July 11 issue of the Journal of the American Medical Association.

 

H1N1 flu vaccination linked to small but significantly increased risk of Guillain-Barré

Share |

Comments: (0)

Tell-a-Friend

 

  Advertisement

TUESDAY, July 10 (HealthDay News) -- Exposure to adjuvanted influenza A(H1N1)pdm09 vaccination during pregnancy does not increase the risk of adverse fetal outcomes, and influenza vaccination correlates with a small but significantly increased risk of Guillain-Barré Syndrome (GBS), according to two studies published in the July 11 issue of the Journal of the American Medical Association.

Björn Pasternak, M.D., Ph.D., from the Statens Serum Institut in Copenhagen, Denmark, and colleagues examined the risk of adverse fetal outcomes for infants exposed to an adjuvanted influenza A(H1N1)pdm09 vaccine during pregnancy in propensity score-matched analyses of a Danish cohort. The researchers found that there was no significantly increased risk of a major birth defect for infants exposed in the first trimester versus unexposed infants. There was also no increased risk for preterm birth or small for gestational age for those exposed in the first trimester, or the second or third trimesters, versus unexposed infants.

Philippe De Wals, Ph.D., from the Université Laval in Québec, and colleagues examined the risk of GBS after pandemic influenza A(H1N1) vaccine administration in Québec in 2009. The researchers identified 83 cases of GBS over a six-month period, 25 of which had been vaccinated eight or fewer weeks before disease onset. In the eight-week postvaccination period, the age- and sex-adjusted relative risk was 1.80 for all confirmed cases and, in the four-week postvaccination period, the relative risk was 2.75. Per one million doses, approximately two cases of GBS were attributable to vaccination.

"In Québec, the 2009 influenza A(H1N1) vaccine was associated with a small but significant risk of GBS," De Wals and colleagues conclude. "It is likely that the benefits of immunization outweigh the risks."

Several authors from the de Wals study disclosed financial ties to the pharmaceutical industry.

Abstract - Pasternak
Full Text
Abstract - De Wals
Full Text
Editorial

Copyright © 2012 HealthDay. All rights reserved.


Previous: Breastfeeding Linked to Lower BMI in Postmenopausal Women Next: Acadesine Doesn't Improve Outcomes After CABG

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

 
     

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2016
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.